Trial Profile
Pivotal trial of reovirus in patients with locoregionally recurrent or distally metastatic squamous cell carcinoma of the head and neck.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 08 Oct 2012
Price :
$35
*
At a glance
- Drugs Pelareorep (Primary)
- Indications Head and neck cancer
- Focus Registrational; Therapeutic Use
- 08 Oct 2012 New trial record